In European countries, 1.1% to 1.6% of live births are before 33 weeks' gestation. 1, 2 Although advances in neonatal intensive care have resulted in an increased survival rate, survivors are still at considerable risk of developing neurological problems such as cognitive, behavioural, neurosensory, and motor disabilities. [2] [3] [4] Neonatologists face the difficult task of informing parents about the possible consequences of preterm birth on the future life of their child and are often challenged to do this at a very early stage. Prediction is classically based on a combination of neuroimaging studies, such as cranial ultrasound (CUS) and magnetic resonance imaging (MRI), and neurophysiological testing, such as electroencephalography (EEG) and somatosensory evoked potentials (SSEPs). Typically, this information becomes available step by step, usually starting with an early CUS around the end of the first week and closing with a brain MRI around term-equivalent age. 5, 6 Several studies have examined the accuracy of the different tests in predicting neurological outcome. Cerebral abnormalities seen on serial CUS during the first weeks of life and on MRI at term-equivalent age have been shown to be associated with motor and cognitive impairment and hearing or visual deficiencies. [7] [8] [9] EEG and SSEPs are used to determine the integrity of the nervous system and have been shown to be useful in predicting the risk of developing cerebral palsy (CP) or cognitive disabilities. [10] [11] [12] [13] [14] However, studies comparing the predictive power of the different tests in the same study population are limited. Moreover, studies have failed to report on likelihood ratios, which are clinically more useful than sensitivities, specificities, or predictive values. The likelihood ratio has the advantage, in contrast to the predictive value, of being independent of the prevalence of the outcome.
The aim of this study was to compare the accuracy of the most commonly used tests (early and late CUS, EEG, SSEP, and MRI) in predicting adverse neurological outcome at 2 years 6 months corrected age in survivors of a population of infants born very preterm. To optimize applicability of the results for populations with a different prevalence for the outcomes, we calculated the likelihood ratios of positive and negative test results.
METHOD Patients
A retrospective study was performed on the medical files of all infants born preterm with a gestational age of less than 32 weeks admitted in the neonatal intensive care unit of the University Hospital Brussels, Belgium, between the 1st January 2008 and the 31st December 2012. During this period, routine diagnostic evaluations consisted of repeated CUS examinations, EEG, SSEP, and MRI at term-equivalent age. Neurological assessment on follow-up was performed on a regular basis by a paediatric neurologist; a cognitive and motor Bayley assessment was performed at the corrected age of 2 years 6 months. Children who died before neurological assessment or who were lost to followup were excluded. The study was approved by the local ethics committee.
Diagnostic testing Early CUS
An early CUS was performed between days 4 and 14 of life. A high-resolution, real-time, mobile two-dimensional ultrasound machine was used, with multiple transducers with a band of frequencies. Typically a probe with a frequency of 7.5MHz to 8.5MHz gave good quality. CUS was performed under supervision of an experienced radiologist (CE), specialized in paediatric imaging, who was blinded for the results of SSEP and EEG. Presence and extent of intracranial haemorrhage were assessed and categorized as grade 1 (subependymal bleeding), grade 2 (intraventricular blood filling <50% of the ventricle without dilatation), or grade 3 (intraventricular blood filling ≥50% of the ventricle with acute dilatation), with or without the presence of an intraparenchymal haemorrhage or stroke. For the study, results of early CUS were dichotomized into either normal findings or the presence of a grade 1 or grade 2 haemorrhage (negative test result), or the presence of a grade 3 or an intraparenchymal haemorrhage or stroke (positive test result). 15 
Somatosensory evoked potentials
Bilateral cortical SSEP was performed at the posterior tibial nerve around 32 weeks postmenstrual age. The SSEP was recorded with an evoked potential response unit from Nicolet (model Viking IV P, Middleton, WI, USA). Electrical pulses of 0.2ms duration were delivered using electrodes placed at the ankle along the posterior tibial nerve, with the cathode proximally. The interelectrode distance was approximately 1cm. The stimulus frequency was 0.5Hz. The scalp electrodes were placed at Fz and Cz. An amplifier bandpass filter of 5Hz to 1.5kHz was used with an analysis time of 200ms. Because of the higher prevalence of leg involvement compared with arm involvement in CP in infants born preterm, and the better predictive value of SSEP after stimulation of the posterior tibial nerve compared with the median nerve, the first was chosen. 13 The test was performed and interpreted by a single paediatric neurologist (DH) with specific expertise in neonatal neurology. Owing to the retrospective design of the study, she was not blinded for the clinical condition of the infant, nor for CUS findings. A test was considered positive in case of an absent (no identifiable answer), delayed (an absolute latency greater than the 95% predictive intervals for normal outcome), or asymmetrical (a difference in latency time of more than 10ms or a unilateral abnormal latency) answer. 14 
Late CUS
A late CUS was performed between 4 weeks and 6 weeks postnatal age. Besides sequelae of intracranial haemorrhage, assessment focused on signs of white matter damage. Late CUS was considered abnormal (positive test result) in case of sequelae of grade 3 intracranial haemorrhage, cystic periventricular leukomalacia, porencephalic cyst, non-progressive persistent ventricular dilatation, or posthaemorrhagic hydrocephalus requiring treatment. Presence of sequelae of a grade 1 or 2 intracranial haemorrhage, as well as persistent flaring in the periventricular white matter, were considered as a negative test result. 15 
Electroencephalography
An EEG was routinely performed at 33 to 34 weeks postmenstrual age. The EEG was conducted by placing nine bipolar conduction electrodes according to the modified 10-20 international system (Fp1, Fp2, T3, T4, C3, C4, O1, O2, Cz), combined with electro-oculography, electrocardiography, and respiratory movement measurement. The time constant was 0.3 seconds, a lowpass filter was set at 70Hz, and amplitudes were 10lV/mm. All EEGs were interpreted by two paediatric neurologists (DH and AJ [see Acknowledgements]) with specific expertise in neonatal encephalography. There was no blinding for the clinical condition or for the results of the CUS and SSEP. A positive test result was defined in the case of immature or dysmature tracing (the presence of EEG patterns that were ≥2wks immature), disorganization (asymmetry or deformed morphology of d waves and brushes), the presence of convulsions (rhythmic discharges), or positive Rolandic sharp waves. 10 Brain MRI A brain MRI was performed at term-equivalent age. MRI imaging was undertaken by using a Discovery MR750 3.0T magnetic resonance system from GE Healthcare. MRI protocol specifications were as follows: axial (silent) T2-weighted sequence (repetition time 1142ms, echo time 153ms, 3mm slice thickness); sagittal three-dimensional cube T2-weighted sequence (repetition time 3440ms, echo time 118ms, 1.4mm slice thickness); T1 fluid attenuation inversion recovery (repetition time 3455ms, echo time What this paper adds
• An abnormal early cranial ultrasound (positive test result) is the best predictor of adverse neurodevelopmental outcome.
• All negative results have poor predictive value of future neurodevelopmental problems.
30ms, 3mm slice thickness); sagittal three-dimensional brain volume imaging T1-weighted sequence (repetition time 10.3ms, echo time 4.3ms, TI 850, 1.2mm slice thickness); axial T2-star weighted angiography (repetition time 50.6ms, echo time 24.5ms, 2mm slice thickness); diffusion weighted imaging (b0, b800, repetition time 4808ms, echo time 78.2ms, 5mm slice thickness). MRIs were interpreted by one of two experienced paediatric radiologists (TV and BD [see Acknowledgements]) who were unaware of the results of SSEP and EEG, and of the clinical condition of the child. MRI was considered abnormal (positive test result) in the case of cystic periventricular haemorrhagic lesions (sequelae of a venous infarct), reduced cortical growth (in the context of an overall reduced brain growth), a porencephalic cyst, an infarct, or a hydrocephalus (ventricular enlargement above the 97th centile for the estimated gestational age needing treatment). Delayed myelinization and sequelae of a grade 1 or 2 intracranial haemorrhage were considered as a negative test result. 16 Cerebellar abnormalities were searched for, but were absent in our population.
Neurological outcome
All infants were invited for a neurological evaluation at the corrected age of 2 years 6 months. They were examined by a paediatric neurologist for signs of motor impairment or CP. A Bayley II assessment was performed with cognitive and motor developmental scores. Adverse neurological outcomes were defined as the presence of motor impairment or CP on clinical examination, a cognitive developmental score of less than 85, or a motor developmental score of less than 85. 17 Follow-up was performed in a specific centre specializing in developmental disorders, with experienced paediatric neurologists and speech and physical therapists trained for the evaluation of infants born preterm.
Statistical analysis
Statistical analysis was performed using the R statistical package. 18 For the descriptive analysis, differences in proportions between groups were analysed using a v² test or Fisher's exact test as appropriate. Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio of a positive test, likelihood ratio of a negative test, and their 95% confidence intervals were calculated for each test and the outcome parameters (motor impairment or CP, cognitive and motor developmental scores on the Bayley assessment). Posttest probabilities in the case of positive and negative tests were calculated. McNemar testing was performed to compare the value of the different diagnostic tests (Appendix S1, online supporting information). A p value of less than 0.05 was considered significant.
RESULTS

Population characteristics
From 2008 until 2012, 377 infants were born with a gestational age below 32 weeks and admitted to the neonatal intensive care unit. Of those, 163 children could be included in our analysis. Forty-one children died during the neonatal period, three shortly after, and 170 children were lost to follow-up. The deceased children were generally born extremely preterm (mean gestational age 26wks, range 24wks-31wks 6d), and death occurred most often within the first 3 days of life. The main causes of death were sepsis and severe respiratory distress syndrome. Of the 163 children who were assessed at the age of 2 years 6 months, 86 were female (52.8%) and 142 infants (87.1%) were white. The mean (outlier) gestational age at birth was 29 weeks (24wks 5d; 31wks 6d). The mean (outlier) birthweight was 1225 grams (520; 2030). Twenty-two (13.6%) infants had intrauterine growth restriction, defined as a weight for gestational age below the 10th centile. 19 Of the 163 children assessed at the corrected age of 2 years 6 months (mean 27.5mo; SD 3.3), 131 (80.4%) had a normal neurological examination, 11 (6.7%) had symptoms of hemiplegia, 13 (8%) had symptoms of diplegia, and eight (4.9%) had symptoms of quadriplegia. Therefore, the prevalence of abnormal neurological examination was 19.6%.
A cognitive developmental assessment was performed in all children. One hundred and ten (67.5%) had a cognitive developmental score of 85 or more (prevalence of cognitive developmental delay of 32.5%). Motor developmental assessment was performed in 143 (87.7%) children, of whom 69 (48.3%) had a score of 85 or more (prevalence of motor developmental delay of 51.7%).
A normal neurological examination in combination with a normal score on the motor and cognitive developmental assessment was found in 60 (36.8%) children. The combination of an abnormal neurological examination and abnormal motor and cognitive developmental assessment was found in 15 (9.2%) children.
Individual test results
An overview of the results of the EEG, SSEP, early and late CUS, and MRI versus the outcome is presented in Table I .
An early CUS was performed in 162 infants. An abnormal early CUS result was significantly associated with abnormal neurological examination (p<0.001) and cognitive developmental delay (p=0.001), but not with motor developmental delay (p=0.080). For the neurological evaluation, the early CUS had a false positive rate of 4.6% and a false negative rate of 72.7%. For motor and cognitive developmental delay, we found false positive rates of 4.4% and 3.7% and false negative rates of 86.5% and 79.2% respectively.
An SSEP was performed in 158 infants. An abnormal SSEP result was not significantly associated with an abnormal neurological examination nor with a motor or cognitive developmental delay. The false positive and false negative rates were 8.7% and 80.6% for the neurological evaluation, 4.6% and 86.3% for motor developmental delay, and 8.4% and 84.3% for cognitive developmental delay.
A late CUS was performed in 162 infants. An abnormal late CUS was significantly associated with neurological abnormality (p<0.001) and cognitive developmental delay (p=0.004), but not with a motor developmental delay (p=0.051). False positive and false negative rates were 9.2% and 62.5% for the neurological evaluation, 8.7% and 79.7% for motor developmental delay, and 9.1% and 73.6% for cognitive developmental delay.
An EEG was performed in 153 infants. An abnormal EEG was significantly associated with an abnormal neurological examination (p=0.016) and motor developmental delay (p=0.011), but not with cognitive developmental delay (p=0.151). False positive and false negative rates were 13.3% and 68.7% for neurological abnormality, 8.1% and 75.3% for motor developmental delay, and 13.9% and 76.9% for cognitive developmental delay.
An MRI was performed in 144 infants. An MRI being classified as abnormal was significantly associated with all three outcomes (p<0.001 for neurological abnormality, p=0.02 for motor developmental delay, and p=0.010 for cognitive developmental delay). False positive rates were somewhat higher than for the previous tests (21.2% for neurological abnormality, 15.2% for motor developmental delay, 22.6% for cognitive developmental delay), whereas false negative rates were slightly lower (55.8%, 59.7%, and 56.9% respectively).
In total we found 73 children who tested normal for all the performed tests. Of these children, 89% had a normal neurological development, 55.9% had no motor developmental delay, and 73% had no cognitive developmental delay. This means that, if for a specific infant of this population of infants born preterm all test results came back normal, the probability of an abnormal neurological examination at the corrected age of 2 years 6 months decreased from 20% to 11%, of motor developmental delay from 47% to 44.1%, and of cognitive developmental delay from 30% to 27%.
Only one child had abnormal results for all the tests and showed symptoms of quadriplegia, and had a motor and cognitive developmental delay.
Only a few of the deceased children received diagnostic tests. Overall, we found a higher number of abnormal tests in these patients. An early CUS was performed in 20 of them and an abnormal result was found in four (20%). Seven children received an SSEP. Three (42.9%) had an abnormal result. An EEG was performed in eight, of whom three (37.5%) showed abnormalities. A late CUS was abnormal in three (42.9%) of the seven children in whom it was performed. An MRI was performed in only three children and was abnormal in all of them.
In the children who were lost to follow-up, we found an older median gestational age, a larger median birthweight, and a higher proportion of normal test results, except for the SSEP, where no difference was found. A comparison between the two groups is shown in Table II .
Comparison of the tests
An overview of the sensitivity, specificity, likelihood ratios, and the posttest probabilities is provided in Table III .
Abnormal neurological examination
For neurological abnormality on clinical examination as an outcome, MRI had a significantly higher sensitivity than all other tests, but with a significantly lower specificity than SSEP and early or late CUS. Early CUS had the highest positive likelihood ratio (6.09), meaning that an abnormal early CUS increased the probability of an abnormal neurological examination at 2 years 6 months of age substantially (from 20% pretest-60% posttest in our study sample). MRI performed best in terms of excluding neurological abnormality: with a negative likelihood ratio of 0.49, the probability of having a neurological abnormality when MRI was classified as normal decreased from 20% to 11%.
Motor developmental delay
For a Bayley motor score below 85 as an outcome, MRI again had the highest sensitivity, although it was still quite low (40%). This differed significantly from SSEP and early or late CUS. Early CUS and SSEP had significantly higher specificities (96% and 95% respectively) compared with MRI. The tests with the best positive predictive properties were the early CUS, SSEP, and late CUS (positive likelihood ratio about 3), increasing the probability of motor developmental delay in our study sample from 51.7% to 77% in the case of an abnormal result. None of the tests had good negative predictive properties, with the negative likelihood ratio ranging between 0.70 for MRI, and 0.9 for early CUS and SSEP. This means that a normal test result had very little impact on the probability of motor developmental delay (posttest probabilities ranging between 42% and 49%).
Cognitive developmental delay
For a Bayley cognitive score below 85 as an outcome, sensitivities were again generally low, ranging between 16% All data given (unless specified) as n (%). Q, quartile. and 43%. MRI had a significantly higher sensitivity, but lower specificity than all other tests. Early CUS had the highest specificity (96%). The test with the best positive predictive properties for cognitive developmental delay was an early CUS, with a positive likelihood ratio of 5.66, increasing the probability in our study population from 32.5% to 73% in the case of an abnormal result. Negative likelihood ratios were very poor for all tests, ranging between 0.73 and 0.98, meaning that a normal test result had minimal impact on the probability of cognitive developmental delay (posttest probabilities ranging between 26% and 31%).
DISCUSSION
In this retrospective study, we compared the predictive power of the diagnostic tests that are most commonly used in infants born very preterm during their stay on the neonatal intensive care unit to predict neurological outcome. Neonatologists rely on the results of those tests to inform parents about the possible risks of motor or cognitive developmental delays. Thus, it is important to be aware of the predictive value of a given test result to provide correct information. This is, to our knowledge, the first comparative study reporting on likelihood ratios for the different diagnostic tests. The positive likelihood ratio indicates how much a positive test result increases the probability of having the outcome. The higher the positive likelihood ratio, the better the test performs in confirming the presence of the outcome of interest (good when >10, moderate when 5-10, fair when 2-5, weak when <2). Similarly, the negative likelihood ratio gives information about how much a negative test result can reduce the probability: in other words, whether it is able to exclude the occurrence of the outcome (good when <0.1, moderate when between 0.1-0.2, fair when 0.2-0.5, weak when >0.5).
Using likelihood ratios, a posttest probability can be calculated for each test result and for populations with different prevalences (or pretest probabilities) of the outcome.
In our study population, none of the tests reached good positive or negative predictive properties for any of the neurological outcomes. A CUS in the second week of life showing a severe intraventricular haemorrhage or intraparenchymal bleeding had the best ability to predict later CP or cognitive developmental delay, which was still only moderately good with a negative likelihood ratio around 6. An abnormal early or late CUS and an abnormal SSEP had the best ability to predict later motor developmental delay, with a positive likelihood ratio over 3. A normal test result for CUS, SSEP, or EEG hardly changed the probability of adverse neurological outcome, with negative likelihood ratios ranging between 0.69 and 0.98; therefore it could not be used to reassure parents about the neurological prognosis of their child. Only an MRI at term-equivalent age that was within normal range could reduce the probability of later CP more significantly, although the negative likelihood ratio was still only fair (0.49). To predict normal motor or cognitive development, a negative MRI result was less performant (negative likelihood ratio 0.70 and 0.73 respectively).
A recent systematic review on the prognostic value of the EEG in infants born preterm found high variety in sensitivity (35%-94%) and specificity (67%-100%). 20 Heterogeneity in definitions and study protocols used (EEG variables, neurodevelopmental outcomes, and cut-off values) can explain these differences.
Somatosensory evoked potential performed in infants born preterm in previous reports found a sensitivity varying between 62.5% and 95.5% and a specificity between 50% and 99%.
14 Timing of the SSEP in different studies varied widely. This could be an explanation because the optimal period for performing this test is still under discussion.
The diagnostic value of CUS has also been extensively studied. Reported sensitivities vary between 18% and 96%, and specificities between 69% and 99%. Several other studies have shown equally low sensitivity and high specificity, as was found in our study. The somewhat higher cut-off value we used to categorize a CUS as being abnormal is only part of the explanation, because large differences in sensitivity and specificity were found between studies with similar dichotomization cut-off values. 21 A recent systematic review on the prognostic value of MRI in predicting CP and motor and cognitive developmental delays found a sensitivity of 77%, 72%, and 62% and a specificity of 79%, 62%, and 61% respectively. 22 A high diversity in study design was seen. We opted to use high cut-off values, which resulted in lower sensitivity and higher specificity.
Several limitations of our study need to be mentioned. Firstly, owing to the retrospective design, data were incomplete. Only 135 of the 163 included infants (82.8%) received all the diagnostic tests. Moreover, blinding of outcome assessment was not possible because the paediatric neurologist was aware of test results at the time of the follow-up visit. Although retrospective, our cohort study still represents one of the largest comparing the predictive accuracy of the different neuroimaging and neurophysiological tests in the same study population. Secondly, dropout rate for neurological follow-up was surprisingly high (170/333 infants [51%]), despite repeated invitations sent to the parents. This could have introduced a selection bias and explain the relatively high prevalence of adverse neurological outcomes in our study population compared with the international literature, 2 since the mean gestational age of the children lost to follow-up was 30 weeks 3 days (vs 29wks) and they had a higher rate of normal diagnostic tests. However, using likelihood ratios, clinicians should be able to calculate posttest probabilities for different populations of infants born preterm with different prevalences of adverse neurological outcomes. Thirdly, to calculate likelihood ratios, we dichotomized test results into 'negative' or 'positive'. Although it facilitates clinical applicability, it probably oversimplifies the rather complex clinical situation. Moreover, the accuracy of a diagnostic test strongly depends on the cut-off value that is used to consider a test result as 'positive'. For example, we used a high cut-off value for CUS findings, resulting in a rather low sensitivity (and negative predictive value), but a high specificity (and positive predictive value). In Tables SI and SII (online supporting information) we lowered the cut-off values for early and late CUS and MRI, which resulted in a higher sensitivity and lower specificity.
Considering the results of our study, one could question the usefulness of continuing to perform all those diagnostic tests in the early neonatal period. We argue that, in case of an abnormal result, an early CUS or SSEP can have clinically relevant information for the neonatologist when talking to the parents in this early stage about the risks of adverse neurological outcome. It is crucial, however, to realize that a normal test result should not be used to reassure parents about their child's future neurological development.
In conclusion, in our study population of infants born very preterm, none of the commonly used diagnostic tests to predict later neurodevelopmental problems were very accurate. In general, a 'positive' test result contributed more than a 'negative' test result, with early CUS and SSEP having the strongest positive predictive properties. Overall, tests were very poor in predicting normal neurological outcome, with MRI at term-equivalent age being the most accurate. Neonatologists should therefore be very cautious in communicating with parents, especially after a negative result on the tests in the early neonatal period. tion of the EEGs; and the team of neurologists and speech and physical therapists at the Center for Developmental Disabilities of the University Hospital Brussels for their evaluations and followup of the children. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.
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Appendix S1: McNemar test comparing the diagnostic accuracy of early cranial ultrasound (CUS), somatosensory evoked potential, late CUS, electroencephalography, and magnetic resonance imaging for abnormal neurological examination, motor developmental delay, and cognitive developmental delay. 
